Abstract OBJECTIVE: To investigate the effect of vitamin D on the expression of chemokine regulated on activation, normal T cells expressed and secreted (RANTES) in the lung tissue of asthmatic rats, and the role of vitamin D in the control of asthmatic airway inflammation and the synergistic action of hormones. METHODS: Forty female Wistar rats were randomly and equally divided into normal control, asthma, vitamin D intervention, budesonide intervention, and budesonide+vitamin D intervention groups. Hematoxylin and eosin staining was used to observe pathological changes in the lung tissue. Immunohistochemistry was used to measure the protein expression of RANTES in lung tissue. Enzyme-linked immunosorbent assay was used to measure the level of RANTES in bronchoalveolar lavage fluid (BALF). Real-time quantitative PCR was used to measure the mRNA expression of RANTES. RESULTS: The asthma group showed the most significant pathological changes in the lung tissue, including inflammatory cell infiltration, bronchial stenosis and distortion and smooth muscle rupture, while the intervention groups showed fewer pathological changes. Of the intervention groups, the budesonide intervention group showed fewer pathological changes than the vitamin D intervention group, and the budesonide+vitamin D intervention group showed the mildest pathological changes, which were similar to those observed in the normal control group. Protein expression of RANTES in the lung tissue and BALF was significantly higher in the asthma group than in the normal control group (P<0.05), while it was lower in the intervention groups than in the asthma group, exhibiting significant differences between each intervention group and the asthma group (P<0.05) (except the difference in protein expression of RANTES in BALF between the vitamin D intervention and asthma groups). The budesonide+vitamin D intervention group showed less protein expression of RANTES in the lung tissue and BALF than both the budesonide intervention and vitamin D intervention groups (P<0.05). The mRNA expression of RANTES was significantly higher in the asthma group than in the normal control group (P<0.05), while it was significantly lower in three intervention groups than in the asthma group (P<0.05), however no significant difference was found between the intervention groups in this regard. The budesonide+vitamin D intervention group showed the lowest level of RANTES mRNA, with no significant difference from the normal control group. CONCLUSIONS: The mRNA and protein expression of RANTES in BALF and lung tissue increases significantly in asthmatic rats. Vitamin D intervention can decrease the expression of RANTES, suggesting that vitamin D can reduce airway inflammation by regulating the expression of RANTES. Vitamin D can be used together with budesonide to further decrease the mRNA and protein expression of RANTES.
CHEN Wei-Wei,CAI Xu-Xu,TIAN Wei-Min et al. Expression of RANTES in the lung tissue of asthmatic rats, and the intervention effect of vitamin D on RANTES expression[J]. 中国当代儿科杂志, 2012, 14(11): 863-868.
CHEN Wei-Wei,CAI Xu-Xu,TIAN Wei-Min et al. Expression of RANTES in the lung tissue of asthmatic rats, and the intervention effect of vitamin D on RANTES expression[J]. CJCP, 2012, 14(11): 863-868.
［1］Lukacs NW, Strieter RM, Warmington K, Lincoln P, Chensue SW, Kunkel SL. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation［J］. J Immunol, 1997, 158(9): 4398-4404.
［2］Pan ZZ, Parkyn L, Ray A, Ray P. Inducible lung-specific expression of rantes: preferential recruitment of neutrophils［J］. Am J Physiol Lung Cell Mol Physiol, 2000, 279(4): L658-L666.
［3］Brehm JM, Celedón JC, SotoQuiros ME, Avila L, Hunninghake GM, Forno E, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica［J］. Am J Respir Crit Care Med, 2009, 179(9): 765-771.
［4］Camargo CA Jr, Rifas-Shiman SL, Litonjua AA, Rich-Edwards JW, Weiss ST, Gold DR, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3y of age ［J］. Am J Clin Nutr, 2007, 85(3): 788-795.
［5］Devereux G, Litonjua AA, Turner SW, Craig LC, McNeill G, Martindale S, et al. Maternal vitamin D intake during pregnancy and early childhood wheezing［J］. Am J Clin Nutr, 2007, 85(3): 853-859.
［6］Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippil-C, Ahonen S, Nevalainen J, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children［J］. Clin Exp Allergy, 2009, 39(6): 875-882.
［7］Li M, Shang YX, Wei B, Yang YG. The effect of substance P on asthmatic rat airway smooth muscle cell proliferation, migration, and cytoplasmic calcium concentration in vitro［J］. J Inflamm (Lond), 2011, 8(1): 18.
［9］Zhang YG, Huang J, Zhang J, Li XB, He C, Xiao YL, et al. RANTES gene polymorphisms and asthma risk: A meta-analysis［J］. Arch Med Res, 2010, 41(1): 50-58.
［10］Fang Q, Wang F, Zhao D. Association between regulated upon activation, normal T cells expressed and secreted (RANTES) -28C/G polymorphism and asthma risk--a metaanalysis［J］. Int J Med Sci, 2010, 7(1): 55-61.
［11］Tillie-Leblond I, Hammad H, Desurmont S, Pugin J, Wallaert B, Tonnel AB, et al. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment［J］. Am J Respir Crit Care Med, 2000, 162(2 Pt 1): 586-592.
［12］Gaultier C, Harf A, Balmain N, Cuisinier-Gleizes P, Mathieu H. Lung mechanics in rachitic rats［J］. Am Rev Respir Dis, 1984, 130(6): 1108-1110.
［14］Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense［J］. J Immunol, 2008, 181(10): 7090-7099.
［15］Bartlett JA, Fischer AJ, McCray PB Jr .Innate immune functions of the airway epithelium［J］. Contrib Microbiol, 2008, 15: 147-163.
［16］Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state［J］. J Immunol, 2010, 184(2): 965-974.
［17］Wittke A, Chang A, Froicu M, Harandi OF, Weaver V, August A, et al. Vitamin D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation［J］. Arch Biochem Biophys, 2007, 460(2): 306-313.
［18］Casola A, Henderson A, Liu T, Garofalo RP, Brasier AR. Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation［J］. Am J Physiol Lung Cell Mol Physiol, 2002, 283(6): L1280-L1290.
［19］Li Q, Verma IM. NF-kappaB regulation in the immune system［J］. Nat Rev Immunol, 2002, 2(10): 725-734.
［20］Homma T, Matsukura S, Hirose T, Ohnishi T, Kimura T, Kurokawa M, et al. Cooperative activation of CCL5 expression by TLR3 and tumor necrosis factor-alpha or interferongamma through nuclear factor-kappaB or STAT-1 in airway epithelial cells［J］. Int Arch Allergy Immunol, 2010, 152 (Suppl 1): 9-17.
［22］Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients［J］. J Clin Invest, 2006, 116(1): 146-155.
［23］Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. Vitamin D levels, lung function, and steroid response in adult asthma［J］. Am J Respir Crit Care Med, 2010,181(7): 699-704.
［24］Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DY. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use［J］. J Allergy Clin Immunol, 2010, 125(5): 995-1000.
